Federal Supply Schedule 36F79721D0169
Award Date
6/1/21
Last Date to Order
5/31/26
Federal Agency
Veterans Integrated Service Network 12
Awardee
Regeneron Pharmaceuticals Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Pricing Type
Fixed Price with Economic Price Adjustment
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed
Similar IDVs
This Blanket Purchase Agreement (BPA) was awarded by the Department of Veterans Affairs (VA) to Regeneron Pharmaceuticals Inc., a for-profit pharmaceutical manufacturer. The BPA, which falls under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB), has a ceiling value of $780,000.00 and an ultimate completion date of September 29, 2025.
The primary product being procured under this BPA is the drug EVKEEZA. A firm fixed-price BPA Call Order was issued on November 24, 2021 with a...
This indefinite delivery contract (IDC) was awarded by the Office of the Assistant Secretary for Preparedness and Response, a civilian agency within the U.S. Department of Health and Human Services (HHS). The IDC has a ceiling value of $44,440,563.00 and a period of performance from September 2, 2015 to September 30, 2023.
The primary purpose of this IDC is to support the development of Regeneron's anti-Ebola antibody therapeutics program. Regeneron Pharmaceuticals Inc., a for-profit...
The federal contract indefinite delivery vehicle (IDV) award V797D70252 is a multiple-award Federal Supply Schedule (FSS) contract held by Gilead Sciences Inc. (Gilead) under GSA Schedule 61-IB for Pharmaceuticals and Drugs. The contract has a ceiling value of $5.5 billion and an ultimate completion date of September 29, 2025.
Gilead, a prominent biopharmaceutical company, provides a range of critical pharmaceutical products to the U.S. Department of Veterans Affairs (VA) and other federal...
This Blanket Purchase Agreement was awarded by the Department of Veterans Affairs National Acquisition Center to Regeneron Pharmaceuticals Inc. for the base year plus four option periods with a potential value of $780,000. The BPA utilizes the Pharmaceuticals and Drugs Federal Supply Schedule and has no set-aside designated.
The agreement facilitates the procurement of the drugs Arcalyst and Evkeeza to support the Department of Veterans Affairs' medical programs. Arcalyst treats recurrent...
The federal contract IDV award is a Federal Supply Schedule (FSS) contract under Schedule 65 I B for Drugs, Pharmaceuticals, & Hematology Related Products. The contracting agency is the Department of Veterans Affairs (VA), specifically the Veterans Integrated Service Network 12 (VISN 12). The prime contractor is Reata Pharmaceuticals, Inc., a for-profit organization.
The contract has a ceiling value of $25,000.00 and a period of performance ending on October 23, 2023. It is a multiple...
The federal contract indefinite delivery vehicle (IDV) is a Federal Supply Schedule (FSS) contract awarded by the Department of Veterans Affairs (VA) to ELI Lilly And Company, a for-profit manufacturer of pharmaceutical goods. The contract, valued at up to $3.6 billion, covers the provision of drugs, pharmaceuticals, and hematology-related products under FSS-61-IB.
The IDV has an ordering period through December 31, 2025 and was initially awarded on August 1, 2018. Under this contract, ELI...
The federal contract IDV is a Federal Supply Schedule (FSS) contract awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency, to EMD Serono Inc., a foreign-owned for-profit manufacturer of goods. The contract has a ceiling value of $340,000,000 and a period of performance through December 31, 2029.
The contract is for the procurement of drugs, pharmaceuticals, and hematology-related products under FSS category 65 IB. The scope includes the delivery of these products...
The federal contract indefinite delivery vehicle (IDV) is a Federal Supply Schedule (FSS) contract awarded by the Department of Veterans Affairs (VA) to Sanofi-Aventis U.S. LLC. The FSS contract has a ceiling value of $4,958,982,930 and a period of performance through May 31, 2028. The contract is for the procurement of "DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS" and does not have any set-aside requirements.
Additionally, the contract includes a Blanket Purchase...
The federal contract IDV award is a Federal Supply Schedule (FSS) contract awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency. The contract, awarded to Enzyvant Therapeutics Inc., has a ceiling value of $2,100,100.00 and a period of performance ending on July 31, 2023.
The purpose of the contract is to provide drugs, pharmaceuticals, and hematology-related products under the 65 I B Federal Supply Class. The contract is a multiple-award vehicle, meaning it can...
The federal contract IDV award is a Federal Supply Schedule (FSS) contract under the Pharmaceuticals and Drugs (FSS-61-IB) schedule, awarded to Array Biopharma Inc. by the Veterans Integrated Service Network 12 (VISN 12) of the Department of Veterans Affairs. The contract has a ceiling value of $3,309,320.00 and a period of performance through June 30, 2024.
The contract provides for the delivery of pharmaceuticals, drugs, and hematology-related products to support the healthcare needs of...